These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31827999)

  • 1. Clinical Impact of Next-generation Sequencing in Pediatric Neuro-Oncology Patients: A Single-institutional Experience.
    Barsan V; Paul M; Gorsi H; Malicki D; Elster J; Kuo DJ; Crawford J
    Cureus; 2019 Dec; 11(12):e6281. PubMed ID: 31827999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
    Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
    Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing for pediatric CNS tumors: does it add value in a middle-income country setup?
    Amayiri N; Al-Hussaini M; Maraqa B; Alyazjeen S; Alzoubi Q; Musharbash A; Ibrahimi AK; Sarhan N; Obeidat M; Hawkins C; Bouffet E
    Front Oncol; 2024; 14():1329024. PubMed ID: 38440233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience.
    Cote GM; He J; Choy E
    Oncologist; 2018 Feb; 23(2):234-242. PubMed ID: 28860410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of GlioSeq Next-Generation Sequencing Test in Pediatric and Young Adult Patients With Brain Tumors.
    Roy S; Agnihotri S; El Hallani S; Ernst WL; Wald AI; Santana Dos Santos L; Hamilton RL; Horbinski CM; Wadhwani NR; Born DE; Pollack IF; Nikiforov YE; Nikiforova MN
    J Neuropathol Exp Neurol; 2019 Aug; 78(8):694-702. PubMed ID: 31298284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Profiling of Advanced Malignancies: A Community Oncology Network Experience and Review of Literature.
    Tayshetye P; Miller K; Monga D; Brem C; Silverman JF; Finley GG
    Front Med (Lausanne); 2020; 7():314. PubMed ID: 32760731
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted Sequencing of Malignant Supratentorial Pediatric Brain Tumors Demonstrates a High Frequency of Clinically Relevant Mutations.
    Cole BL; Pritchard CC; Anderson M; Leary SE
    Pediatr Dev Pathol; 2018; 21(4):380-388. PubMed ID: 29173061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making.
    Weiss GJ; Hoff BR; Whitehead RP; Sangal A; Gingrich SA; Penny RJ; Mallery DW; Morris SM; Thompson EJ; Loesch DM; Khemka V
    Onco Targets Ther; 2015; 8():959-67. PubMed ID: 25960669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
    Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
    Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing of 565 neuro-oncology patients at UCLA: A single-institution experience.
    Ji MS; Eldred BSC; Liu R; Pianka ST; Molaie D; Kevan B; Pan S; Lai TJ; Nguyen NT; Chow FE; Yong WH; Cox CD; Reeh DN; Li T; Liau LM; Nghiemphu PL; Cloughesy TF; Li G; Lai A
    Neurooncol Adv; 2020; 2(1):vdaa009. PubMed ID: 32118206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience.
    Salutari V; Ghizzoni V; Carbone MV; Giudice E; Cappuccio S; Fanfani F; Scambia G; Lorusso D
    Int J Gynecol Cancer; 2023 Apr; 33(4):514-520. PubMed ID: 36746489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
    Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
    Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL
    Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [THE BENEFIT OF MOLECULAR ANALYSIS USING NEXT GENERATION SEQUENCING METHODS IN PEDIATRIC "HARD TO TREAT" TUMORS - EXPERIENCE IN A TERTIARY MEDICAL CENTER].
    Nitzan-Luques A; Cohen H; Winerb S; Raviv D; Harlev D; Goldstein G
    Harefuah; 2023 Jan; 162(1):24-30. PubMed ID: 36714938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of ultrasound-guided liver tumor biopsy for next-generation sequencing-based clinical sequencing.
    Eso Y; Kou T; Nagai H; Kim YH; Kanai M; Matsumoto S; Mishima M; Arasawa S; Iguchi E; Nakamura F; Takeda H; Takai A; Takahashi K; Ueda Y; Muto M; Seno H
    Hepatol Res; 2019 May; 49(5):579-589. PubMed ID: 30645782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
    Dy GK; Nesline MK; Papanicolau-Sengos A; DePietro P; LeVea CM; Early A; Chen H; Grand'Maison A; Boland P; Ernstoff MS; Edge S; Akers S; Opyrchal M; Chatta G; Odunsi K; Pabla S; Conroy JM; Glenn ST; DeFedericis HT; Burgher B; Andreas J; Giamo V; Qin M; Wang Y; Kanehira K; Lenzo FL; Frederick P; Lele S; Galluzzi L; Kuvshinoff B; Morrison C
    BMC Med Inform Decis Mak; 2019 Jan; 19(1):14. PubMed ID: 30658646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience.
    Marks LJ; Oberg JA; Pendrick D; Sireci AN; Glasser C; Coval C; Zylber RJ; Chung WK; Pang J; Turk AT; Hsiao SJ; Mansukhani MM; Glade Bender JL; Kung AL; Sulis ML
    Front Pediatr; 2017; 5():265. PubMed ID: 29312904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.